Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

An Antiluteogenic Factor in the Anterior Pituitary

Abstract

RECENTLY Evans1 reported the existence of a new pituitary factor, the antagonist, which inhibits follicle development in infantile rats when simultaneously injected with follicle-stimulating extracts from various sources. To avoid misunderstanding, it is proposed to call this factor antifolliculogenic, in contrast with antiluteogenic. At about the same time, Bunde and Greep2 described a regression of persistent corpora lutea in the ovaries of hypophy-sectomized rats by the luteinizing fraction of pituitary extracts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Univ. Californ. Publ. Anat., 1, No. 8, 237 (1936).

  2. Proc. Soc. Exp. Biol. and Med., 35, No. 2, 235 (1936).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

FREUD, J. An Antiluteogenic Factor in the Anterior Pituitary. Nature 139, 880–881 (1937). https://doi.org/10.1038/139880b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/139880b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing